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Abstract: Ghrelin was shown to exhibit protective and therapeutic effect in the gut. Aim of the study
was to investigate the role of sensory nerves (SN) in the protective effect of ghrelin in acute pancreatitis
(AP). Studies were performed on male Wistar rats or isolated pancreatic acinar cells. After capsaicin
deactivation of sensory nerves (CDSN) or treatment with saline, rats were pretreated intraperitoneally
with ghrelin or saline. In those rats, AP was induced by cerulein or pancreases were used for isolation
of pancreatic acinar cells. Pancreatic acinar cells were incubated in cerulein-free or cerulein containing
solution. In rats with intact SN, pretreatment with ghrelin led to a reversal of the cerulein-induced
increase in pancreatic weight, plasma activity of lipase and plasma concentration of tumor necrosis
factor-α (TNF-α). These effects were associated with an increase in plasma interleukin-4 concentration
and reduction in histological signs of pancreatic damage. CDSN tended to increase the severity of AP and
abolished the protective effect of ghrelin. Exposure of pancreatic acinar cells to cerulein led to increase in
cellular expression of mRNA for TNF-α and cellular synthesis of this cytokine. Pretreatment with ghrelin
reduced this alteration, but this effect was only observed in acinar cells obtained from rats with intact SN.
Moreover, CDSN inhibited the cerulein- and ghrelin-induced increase in gene expression and synthesis of
heat shock protein 70 (HSP70) in those cells. Ghrelin exhibits the protective effect in cerulein-induced AP
on the organ and pancreatic acinar cell level. Sensory nerves ablation abolishes this effect.
Keywords: sensory nerves; inflammation; acute pancreatitis; capsaicin; lipase; interleukin-4; tumor
necrosis factor-α; heat shock protein 70
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1. Introduction
Ghrelin is a 28-amino acid peptide originally isolated from the rat and human stomach and is
formed from a 117-amino acid precursor [1–3]. Ghrelin acts via ghrelin receptor. Before the discovery of
ghrelin this receptor was called growth hormone secretagogue receptor—GHS-R [1,3,4]. Early studies
in humans and animals showed that ghrelin strongly stimulates the release of growth hormone from
the pituitary gland [1]. This effect is a result of direct action of ghrelin on ghrelin receptors present on
pituitary somatotrophs; however, ghrelin also stimulates the liberation of growth hormone indirectly by
acting on growth hormone-releasing hormone (GH-RH) positive cells in the hypothalamus triggering
GH-RH secretion [5]. In turn, GH-RH acting on the anterior part of the pituitary gland promotes the
release of growth hormone. Another early discovered function of ghrelin is its effect on the energy
balance of the body. Ghrelin induces body mass gain by increase in food intake and decrease in fat
utilization [3,6,7].
The ghrelin receptor is present mainly in the pituitary gland and hypothalamus, but its existence
was also found in other tissues of the body such as the thyroid gland, pancreas, spleen, myocardium,
adrenal gland, gonad, heart, lung and cells of the immunological system [8–10]. Previous studies
showed that ghrelin exhibits protective and therapeutic effect in the digestive tract. Pretreatment with
this polypeptide inhibits the development of different experimental models of gastric lesions [11–13],
as well as exhibits therapeutic effect in the course of oral [14], gastric [15,16] and duodenal [15,17] ulcers.
In addition, most experimental studies on the role of ghrelin in colitis indicates that administration
of this peptide exhibits protective and therapeutic effect in the large bowel [18–23]. Protective and
therapeutic effect of ghrelin was also found in the pancreas. Pretreatment with ghrelin inhibits the
development of acute pancreatitis induced by cerulein [24], taurocholate [25] and pancreatic ischemia
followed by reperfusion [26]. Administration of ghrelin after induction of acute pancreatitis accelerates
the recovery in this disease [27–29]. Moreover, treatment with this peptide attenuates the severity of
acute lung injury in taurocholate-induced acute pancreatitis [30].
Primary unmyelinated capsaicin-sensitive sensory neurons play a nociceptive role and convey
signals, mainly pain signals from the skin and internal environment of the body to the central nervous
system. However, stimulation of these neurons also leads to release of neuromediators from their
peripheral endings [31,32]. Capsaicin, a main pungent ingredient of chili pepper, binds to specific
vanilloid (capsaicin) receptors present on capsaicin-sensitive sensory neurons [33,34]. This receptor
is a nonselective cation channel and belongs to the transient receptor potential family. The current
name of this receptor is the transient receptor potential vanilloid 1 (TRPV1) [33,34]. Low doses of
capsaicin act on TRPV1 and stimulate primary sensory nerves by opening the nonselective cation
channels. It leads to a local release of neuromediators such as calcitonin gene-related peptide (CGRP)
and substance P [31–33]. In contrast, high neurotoxic doses of capsaicin lead to ablation of sensory
nerves and decrease plasma and tissue level of CGRP [35]. Capsaicin-sensitive sensory nerves are
involved in the maintenance of organ integrity in the gut. In the stomach, stimulation of sensory nerves
by low doses of capsaicin or administration of exogenous CGRP before induction of ulcers exhibit a
preventive effect in different experimental models of gastric ulcers [36,37], whereas the ablation of
sensory nerves by neurotoxic doses of capsaicin aggravates gastric damage [38] and delays the healing
of gastric ulcers [39].
Similar effects were observed in the pancreas. Ablation of capsaicin-sensitive sensory nerves
before induction of acute pancreatitis increases the severity of this disease evoked by cerulein or
pancreatic ischemia followed by reperfusion [40,41]. In contrast, stimulation of sensory nerves by low
doses of capsaicin or pretreatment with CGRP before induction of acute pancreatitis exhibits protective
effect in the pancreas and reduces the severity of cerulein- [42,43] and ischemia/reperfusion-induced
acute pancreatitis [41]. On the other hand, administration of CGRP after induction of acute pancreatitis
or persistent activity of sensory nerves increases the severity of acute pancreatitis and lead to functional
insufficiency of the pancreas typical for chronic pancreatitis [44,45]. Moreover, there are studies
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showing that activation of TRPV1 may promote neurogenic inflammation in the pancreas via a release
of substance P and activation of the neurokinin-1 receptor [46–48].
The aim of our present study was to investigate and compare the effect of intraperitoneal
administration of ghrelin on the development of cerulein-induced acute pancreatitis in rats
with intact sensory nerves or sensory nerve ablation evoked by neurotoxic doses of capsaicin.
Moreover, this study was designated to assess the effect of ablation of sensory nerves and
administration of ghrelin performed before isolation of pancreatic acinar cells on expression of mRNA
for tumor necrosis factor-α (TNF-α) and heat shock protein 70 (HSP70), and synthesis of those proteins
by pancreatic acinar cells incubated in the cerulein-containing or cerulein-free medium.
2. Results
2.1. In Vivo Studies
Subcutaneous infusion of cerulein at a dose of 5 µg/kg/h for 5 h (1 mL/h), caused acute
edematous pancreatitis in all animals subjected to this procedure.
2.1.1. Effect of Ghrelin Administered Intraperitoneally on Pancreatic Weight and Histological Signs of
Acute Pancreatitis
In rats from the control sensory nerves-intact group treated with saline, pancreatic weight reached
800 ± 65 mg (Figure 1). Intraperitoneal administration of increasing doses of ghrelin, 12.5, 25 or
50 µg/kg, failed to affect significantly this parameter in sensory nerves-intact rats without induction
of acute pancreatitis.Int. J. Mol. Sci. 2017, 18, 1402  4 of 27 
 
 
Figure 1. Effect of saline or ghrelin (GHRL) given intraperitoneally at a dose of 12.5, 25 or 50 μg/kg 
and cerulein-induced pancreatitis (CIP) on pancreatic weight in sensory nerves-intact rats (SN) or rats 
with capsaicin deactivation of sensory nerves (CDSN). a p < 0.05 compared to the control group with 
intact sensory nerves and without induction of CIP; b p < 0.05 compared to sensory nerves-intact rats 
with CIP pretreated with saline; c p < 0.05 compared to sensory nerves-intact rats pretreated with 
GHRL at a dose of 50 μg/kg prior to CIP. Mean ± standard error of the mean (SEM) from values 
obtained from 10–15 rats in each experimental group. 
Table 1. Effect of saline or ghrelin (GHRL) given intraperitoneally at increasing doses of 12.5, 25 or 50 
μg/kg on morphological changes of pancreatic tissues in the course of cerulein-induced pancreatitis 
(CIP) in animals with intact sensory nerves or with capsaicin deactivation of sensory nerves. 
Groups Edema (0–3) Infiltration (0–3) Vacuolization (0–3) 
Intact Sensory Nerves 
Control (saline) 0 0 0 
CIP 2–3 2–3 3 
GHRL 12.5 μg/kg  0 0 0 
GHRL 25 μg/kg  0 0 0 
GHRL 50 μg/kg 0 0 0 
GHRL 12.5 μg/kg + CIP 2–3 2 2–3 
GHRL 25 μg/kg + CIP 2 1–2 2–3 
GHRL 50 μg/kg + CIP 1–2 1–2 2 
Capsaicin Deactivation of Sensory Nerves 
Saline 0 0 0 
CIP 2–3 2–3 3 
GHRL 50 μg/kg + CIP 3 2–3 3 
GHRL 50 μg/kg 0 0 0 
Numbers represent the predominant histological grading in each experimental group. 
In sensory nerves-intact rats pretreated with saline, infusion with cerulein led to the 
development of acute pancreatitis. Macroscopically it was manifested as a marked swelling of the 
pancreas. Microscopic evaluation revealed pancreatic interlobular edema and moderate or severe 
intralobular edema accompanied by moderate perivascular and scarce diffuse inflammatory 
infiltration or abundant diffuse inflammatory infiltration. In most cases, vacuolization was observed 
in more than 50% of acinar cells. No necrosis or hemorrhage was observed. In these groups of rats, 
total histological score reached a value of 7.60 ± 0.27 (Figure 3). In rats with intact sensory nerves, 
administration of ghrelin before generation of CIP led to reduction in morphological signs of acute 
pancreatitis, as compared to sensory nerves-intact rats treated with saline before induction of CIP 
(Figures 2 and 3, Table 1). 
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Figure 1. Effect of saline or ghrelin (GHRL) given intraperitoneally at a dose of 12.5, 25 or 50 µg/kg and
cerulein-induced pancreatitis (CIP) on pancreatic weight in sensory nerves-intact rats (SN) or rats with
capsaicin deactivation of sensory nerves (CDSN). a p < 0.05 compared to the control group with intact
sensory nerves and without induction of CIP; b p < 0.05 compared to sensory nerves-intact rats with
CIP pretreated with saline; c p < 0.05 compared to sensory nerves-intact rats pretreated with GHRL at
a dose of 50 µg/kg prior to CIP. Mean ± standard error of the mean (SEM) from values obtained from
10–15 rats in each experimental group.
Subcutaneous infusion of cerulein induced pancreatic edema and significantly increased
pancreatic weight in sensory nerves-intact rats to a level of 1780 ± 150 mg. Intraperitoneal
administration of ghrelin at a doses of 25 or 50 µg/kg, 30 min prior to the commencement of
cerulein infusion, resulted in a statistically significan reduction in the cerulei -induced increase
in pancreatic weight in rats with intact sensory erves, to a level of 1259 ± 95 mg and 944 ± 65 mg,
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respectively (Figure 1). Ghrelin given at a dose of 12.5 µg/kg was without a significant effect on
pancreatic weight in sensory nerves-intact rats infused subcutaneously with cerulein.
Capsaicin deactivation of sensory nerves (CDSN) tended to enhance the cerulein-evoked increase
in pancreatic edema and pancreatic weight. However, the difference between pancreatic weight in
sensory nerves-intact rats treated with saline before cerulein infusion and rats with CDSN treated with
saline before cerulein infusion was not statistically significant.
CDSN abolished the ghrelin-induced reduction in cerulein-evoked increase in pancreatic weight.
In rats with CDSN pretreated with ghrelin prior to the development of cerulein-induced pancreatitis
(CIP), pancreatic weight reached a value of 2050 ± 150 mg and was even slightly increased in
comparison to pancreatic weight observed in sensory nerves-intact rats without pretreatment with
ghrelin before induction of acute pancreatitis or rats with CDSN pretreated with saline before CIP.
Pancreatic weight in rats with CDSN treated with ghrelin given at a dose of 50 µg/kg before induction
of CIP was significantly higher than that observed in sensory nerves-intact rats pretreated with the
same dose of ghrelin before CIP development.
Administration of ghrelin at a dose of 50 µg/kg did not alter pancreatic weight in rats with CDSN
without CIP (Figure 1).
Pancreases, obtained from control sensory nerves-intact rats treated with saline without
CIP, were characterized by normal morphology in both, macro- and microscopic evaluation
(Figures 2 and 3, Table 1). In sensory nerves-intact rats without induction of CIP, administration of
ghrelin at doses used failed to affect morphology of the pancreas (Figure 3, Table 1).
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Figure 1. Histological images of pancreatic tissues stained with hematoxylin and eosin, 
magnification 400×: (A) control sensory-nerves-intact rats treated with saline without 
cerulein-induced pancreatitis (CIP); (B) sensory-nerves-intact rats treated with saline followed by 
CIP development; (C) rats with capsaicin deactivation of sensory nerves treated with saline 
followed by CIP development; and (D) sensory-nerves-intact rats treated with ghrelin given at a 
dose of 50 µg/kg followed by CIP development. 
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Figure 1. Histological images of pancreatic tissues stained with hematoxylin and eosin, magnification
400×: (A) control sensory-nerves-intact rats treated with saline without cerulein-induced pancreatitis
(CIP); (B) sensory-nerves-intact rats treated with saline followed by CIP development; (C) rats with
capsaicin deactivation of sensory nerves treated with saline followed by CIP development; and (D)
sensory-nerves-intact rats treated with ghrelin given at a dose of 50 µg/kg followed by CIP development.
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Figure 2. Histological images of pancreatic tissues stained with hematoxylin and eosin, magnification
400×: (A) control sensory nerves-intact rats treated with saline without cerulein-induced pancreatitis
(CIP); (B) sensory nerves-intact rats treated with saline followed by CIP development; (C) rats
with capsaicin deactivation of sensory nerves treated with saline follo ed by CIP development;
and (D) Sensory nerves-intact rats treated with ghrelin given at a dose of 50 µg/kg followed by
CIP development.
In sensory nerves-intact rats pretreated with saline, infusion with cerulein led to the development
of acute pancreatitis. Macroscopic lly it was manifested as a marked swelling of the pancreas.
Microscopic evaluation revealed pancreatic interlobular edema and moderate or severe intralobular
edema accompanied by moderate perivascular and scarce diffuse inflammatory infiltration or abundant
diffuse inflammatory infiltration. In most cases, vacuolization was observed in more than 50% of
acinar cells. No necrosis or hemorrhage was observed. In these groups of rats, total histological score
reached a value of 7.60 ± 0.27 (Figure 3). In rats with intact sensory nerves, administration of ghrelin
before generation of CIP led to reduction in morphological signs of ute pancreatitis, as compared to
sensory nerv s-intact rats tr ated with salin befor induction of CIP (Figures 2 a d 3, Table 1).
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Figure 3. Effect of saline or ghrelin (GHRL) given intraperitoneally at a dose of 12.5, 25 or 50 μg/kg 
and cerulein-induced pancreatitis (CIP) on total histological score in sensory nerves-intact rats (SN) 
or rats with capsaicin deactivation of sensory nerves (CDSN). a p < 0.05 compared to the control group 
with intact sensory nerves and without induction of CIP; b p < 0.05 compared to sensory nerves-intact 
rats with CIP pretreated with saline; c p < 0.05 compared to sensory nerves-intact rats pretreated with 
GHRL at a dose of 50 μg/kg prior to CIP. Mean ± SEM from values obtained from 10–15 rats in each 
experimental group. 
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Figure 3. Effect of saline or ghrelin (GHRL) given intraperitoneally at a dose of 12.5, 25 or 50 µg/kg
and cerulein-induced pancreatitis (CIP) on total histological score in sensory nerves-intact rats (SN) or
rats with capsaicin deactivation of sensory nerves (CDSN). a p < 0.05 compared to the control group
ith intact sensory nerves and ithout induction of CIP; b p < 0.05 co pared to sensory nerves-intact
rats ith CIP pretreated ith saline; c p < 0.05 co pared to sensory nerves-intact rats pretreated ith
RL at a dose of 50 µg/kg prior to CIP. ean SE fro values obtained fro 10–15 rats in each
experi ental group.
Table 1. Effect of saline or ghrelin (GHRL) given intraperitoneally at increasing doses of 12.5, 25 or
50 µg/kg on morphological changes of pancreatic tissues in the course of cerulein-induced pancreatitis
(CIP) in animals with intact sensory nerves or with capsaicin deactivation of sensory nerves.
Groups Edema (0–3) Infiltration (0–3) Vacuolization (0–3)
Intact Sensory Nerves
Control (saline) 0 0 0
CIP 2–3 2–3 3
GHRL 12.5 µg/kg 0 0 0
GHRL 25 µg/kg 0 0 0
GHRL 50 µg/kg 0 0 0
GHRL 12.5 µg/kg + CIP 2–3 2 2–3
GHRL 25 µg/kg + CIP 2 1–2 2–3
GHRL 50 µg/kg + CIP 1–2 1–2 2
Capsaicin Deactivation of Sensory Nerves
Saline 0 0 0
CIP 2–3 2–3 3
GHRL 50 µg/kg + CIP 3 2–3 3
GHRL 50 µg/kg 0 0 0
Numbers represent the predominant histological grading in each experimental group.
CDSN performed prior to induction of CIP tended to increase the severity of acute pancreatitis in
comparison to findings observed in sensory nerves-intact rats with development of CIP, but this effect
was statistically insignificant (Figures 2 and 3, Table 1).
The usage of ghrelin, at a selected dose of 50 µg/kg, prior to the start of cerulein infusion in the
group of animals with CDSN, failed to improve the morphology of the pancreas. Morphological signs
of pancreatic damage in this group of animals were significantly bigger than that observed in sensory
nerves-intact rats treated with ghrelin at a dose of 50 µg/kg before induction of CIP.
Int. J. Mol. Sci. 2017, 18, 1402 6 of 28
The use of ghrelin without induction of CIP did not affected pancreatic morphology in rats with
intact sensory nerves or rats with CDSN (Figure 3, Table 1).
2.1.2. Plasma Lipase Activity
Plasma lipase activity in control sensory nerves-intact rats treated with saline without induction
of CIP was 100 ± 15 IU/L and remained unchanged following administration of increasing doses of
ghrelin, 12.5, 25 or 50 µg/kg (Figure 4).
Int. J. Mol. Sci. 2017, 18, 1402  6 of 27 
 
2.1.2. Plasma Lipase Activity 
Plasma lipase activity in control sensory nerves-intact rats treated with saline without induction 
of CIP was 100 ± 15 IU/L and remained unchanged following administration of increasing doses of 
ghrelin, 12.5, 25 or 50 μg/kg (Figure 4). 
In sensory nerves-intact rats, induction of acute pancreatitis by cerulein caused a dramatic, 
statistically significant increase in plasma activity of lipase to around 8000 IU/L. In rats with intact 
sensory nerves, administration of ghrelin at increasing doses, 12.5, 25 or 50 μg/kg before the induction 
of CIP, resulted in a statistically significant decrease in plasma activity of this pancreatic digestive 
enzyme to approximately 4000, 1600 and 650 IU/L, respectively (Figure 4). 
CDSN tended to increase plasma activity of lipase in rats with CIP, but this effect was statistically 
insignificant. Administration of ghrelin at a dose of 50 μg/kg before the start of cerulein infusion was 
without significant effect on plasma activity of lipase in rats with CDSN and CIP. 
In addition, administration of ghrelin did not affect plasma activity of lipase in rats with CDSN, 
but without induction of CIP (Figure 4). 
 
Figure 4. Effect of saline or ghrelin (GHRL) given intraperitoneally at a dose of 12.5, 25 or 50 μg/kg 
and cerulein-induced pancreatitis (CIP) on plasma activity of lipase in sensory nerves-intact rats (SN) 
or rats with capsaicin deactivation of sensory nerves (CDSN). a p < 0.05 compared to the control group 
with intact sensory nerves and without induction of CIP ; b p < 0.05 compared to sensory nerves-intact 
rats with CIP pretreated with saline; c p < 0.05 compared to sensory nerves-intact rats pretreated with 
GHRL at a dose of 50 μg/kg prior to CIP. Mean ± SEM from values obtained from 10–15 rats in each 
experimental group. 
2.1.3. Pancreatic Blood Flow 
Intraperitoneal administration of increasing doses of ghrelin, 12.5, 25 or 50 μg/kg, did not affect 
pancreatic blood flow in sensory nerves-intact rats without induction of acute pancreatitis (Figure 5). 
In sensory nerves-intact rats, the development of CIP significantly reduced pancreatic blood 
flow by about 40%. Pretreatment with ghrelin at doses used, 30 min before the start of cerulein 
infusion, failed to significantly affect pancreatic blood flow in sensory nerves-intact rats or rats with 
CDSN. CDSN in rats pretreated with saline before CIP tended to further decrease in pancreatic blood 
flow, but this effect was statistically insignificant. On the other hand, we found a significant difference 
in pancreatic blood flow between two groups of rats without CIP: rats with intact sensory nerves 
treated with ghrelin given at a dose of 50 μg/kg and rats with CDSN treated with the same dose of 
this polypeptide. CDSN reduced pancreatic blood flow by almost 30% (Figure 5). 
Figure 4. Effect of saline or ghrelin (GHRL) given intraperitoneally at a dose of 12.5, 25 or 50 µg/kg
and cerulein-induced pancreatitis (CIP) on plasma activity of lipase in sensory nerves-intact rats (SN)
or rats with capsaicin deactivation of sensory nerves (CDSN). a p < 0.05 compared to the control group
with intact sensory nerves and without induction of CIP ; b p < 0.05 compared to sensory nerves-intact
rats with CIP pretreated with saline; c p < 0.05 compared to sensory nerves-intact rats pretreated with
GHRL at a dose of 50 µg/kg prior to CIP. Mean ± SEM from values obtained from 10–15 rats in each
experimental group.
In sensory nerves-intact rats, induction of acute pancreatitis by cerulein caused a dramatic,
statistically significant increase in plasma activity f lipase to around 8000 IU/L. In rats with intact
sensory nerves, administration of ghrelin at increasing doses, 12.5, 25 or 50 µg/kg before the ind ction
of CIP, resulted in a statistically significant decrease in plasma activity of this pancreatic digestive
enzyme to approximately 4000, 1600 and 650 IU/L, respectively (Figure 4).
CDSN tended to increase plasma activity of lipase in rats with CIP, but this effect was statistically
insignificant. Administration of ghrelin at a dose of 50 µg/kg before t e start of cerulein infusion was
without significant effect on plasma activity of lipase in rats with CDSN and CIP.
I addition, a ministration of ghrelin did n t affect plasma activity of lipase in rats with CDSN,
but without induction of CIP (Figure 4).
2.1.3. Pancreatic Blood Flow
Intraperitoneal administration of increasing doses of ghrelin, 12.5, 25 or 50 µg/kg, did not affect
pancreatic blood flow in sensory nerves-intact rats without induction of acute pancreatitis (Figure 5).
In sensory nerves-intact rats, the development of CIP significantly reduced pancreatic blood flow
by about 40%. Pretreatment with ghrelin at doses used, 30 min before the start of cerulein infusion,
failed to significantly affect pancreatic blood flow in sensory nerves-intact rats or rats with CDSN.
CDSN in rats pretreated with saline before CIP tended to further decrease in pancreatic blood flow,
but this effect was statistically insignificant. On the other hand, we found a significant difference
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in pancreatic blood flow between two groups of rats without CIP: rats with intact sensory nerves
treated with ghrelin given at a dose of 50 µg/kg and rats with CDSN treated with the same dose of
this polypeptide. CDSN reduced pancreatic blood flow by almost 30% (Figure 5).Int. J. Mol. Sci. 2017, 18, 1402  7 of 27 
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Figure 5. Effect of saline or ghrelin (GHRL) given intraperitoneally at a dose of 12.5, 25 or 50 µg/kg
and cerulein-induced pancreatitis (CIP) on pancreatic blood flow in sensory nerves-intact rats (SN) or
rats with capsaicin deactivation of sensory nerves (CDSN). a p < 0.05 compared to the control group
with intact sensory nerves and without induction of CIP; b p < 0.05 compared to sensory nerves-intact
rats pretreated with GHRL at a dose of 50 µg/kg without induction of CIP. Mean ± SEM from values
obtained from 10–15 rats in each experimental group.
2.1.4. Plasma Concentration of Tumor Necrosis Factor-α (TNF-α) and Interleukin-4
Plasma concentration of the pro-inflammatory cytokine, TNF-α in the control group of animals
with intact sensory nerves and treated with saline was 5.1 ± 0.5 pg/mL and remained unchanged
following treatment with increasing doses of ghrelin, 12.5, 25 or 50 µg/kg (Figure 6).Int. J. Mol. Sci. 2017, 18, 1402  8 of 27 
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Figure 7. Effect of saline or ghrelin (GHRL) given intraperitoneally at a dose of 12.5, 25 or 50 μg/kg 
and cerulein-induced pancreatitis (CIP) on plasma concentration of interleukin-4 (IL-4) in sensory 
nerves-intact rats (SN) or rats with capsaicin deactivation of sensory nerves (CDSN). a p < 0.05 
compared to the control group with intact sensory nerves and without induction of CIP; b p < 0.05 
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obtained from 10–15 rats in each experimental group. 
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and cerulein-induced pancreatitis (CIP) on plasma concentration of tumor necrosis factor-α (TNF-α)
in sensory nerves-intact rats (SN) or rats with capsaicin deactivation of sensory nerves (CDSN).
a p < 0.05 compared to the control group with intact sensory nerves and without induction of CIP;
b p < 0.05 compared to sensory nerves-intact rats with CIP pretreated with saline; c p < 0.05 compared
to sensory nerves-intact rats pr treate with GHRL at a dose of 50 µg/kg prior to CIP. Mea ± SEM
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CIP resulted in a statistically significant increase in the concentration of TNF-α up to
41.0 ± 7.0 pg/mL. Increasing doses of ghrelin, 12.5, 25 or 50 µg/kg given intraperitoneally 30 min
prior to the induction of CIP, resulted in a statistically significant reduction in plasma concentration of
TNF-α to the level of 24.0 ± 2.5, 11.8 ± 1.5, and 9.0 ± 1.0 pg/mL, respectively (Figure 6).
In rats with CDSN treated with saline before induction of CIP, plasma concentration of TNF-α
reached a value of 46.0 ± 8.0 pg/mL. This concentration of TNF-α was higher than that observed
in sensory nerves-intact rats treated with saline before induction of CIP, but this difference was
statistically insignificant. In rats with CDSN, administration of ghrelin at a dose of 50 µg/kg prior
to start of cerulein infusion did not significantly affect plasma level of TNF-α. For this reason, there
was a statistically significant difference in plasma level of TNF-α between sensory nerves-intact rats
pretreated with ghrelin at a dose of 50 µg/kg before induction of CIP and rats with CDSN pretreated
with the same dose of ghrelin before induction of CIP. Pretreatment with ghrelin was without effect on
plasma concentration of TNF-α in rats with CDSN without CIP (Figure 6).
Plasma concentration of anti-inflammatory cytokine, interleukin-4 in control, sensory nerves-intact
rats treated with saline without CIP was 185 ± 20 pg/mL and remained unchanged after administration
of ghrelin at doses used (Figure 7).
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Figure 7. Effect of saline or ghrelin (GHRL) given intraperitoneally at a dose of 12.5, 25 or 50 μg/kg 
and cerulein-induced pancreatitis (CIP) on plasma concentration of interleukin-4 (IL-4) in sensory 
nerves-intact rats (SN) or rats with capsaicin deactivation of sensory nerves (CDSN). a p < 0.05 
compared to the control group with intact sensory nerves and without induction of CIP; b p < 0.05 
compared to sensory nerves-intact rats with CIP pretreated with saline; c p < 0.05 compared to sensory 
nerves-intact rats pretreated with GHRL at a dose of 50 μg/kg prior to CIP. Mean ± SEM from values 
obtained from 10–15 rats in each experimental group. 
2.2. In Vitro Studies Performed on Isolated Pancreatic Acinar Cells Obtained from Rats with Intact or 
Deactivated Sensory Nerves 
2.2.1. Determination of TNF-α Gene Expression and Protein Synthesis 
The gene expression of pro-inflammatory cytokine, TNF-α in isolated rat pancreatic acinar cells 
in the in vitro model was detected in all samples tested. In acinar cells, obtained from control sensory 
Figure 7. Effect of saline or ghrelin (GHRL) given intraperitoneally at a dose of 12.5, 25 or 50 µg/kg
and cerulein-induced pancreatitis (CIP) on plasma concentration of interleukin-4 (IL-4) in sensory
nerves-intact rats (SN) or rats with capsaicin deactivation of sensory nerves (CDSN). a p < 0.05 compared
to the control group with intact sensory nerves and without induction of CIP; b p < 0.05 compared to
sensory nerves-intact rats with CIP pretreated with saline; c p < 0.05 compared to sensory nerves-intact
rats pretreated with GHRL at a dose of 50 µg/kg prior to CIP. Mean ± SEM from values obtained from
10–15 rats in each experimental group.
CIP resulted in a statistically significant increase in the concentration of interleukin-4 to
320 ± 25 pg/mL in rats with intact sensory nerves. Administration of ghrelin at a dose of 12.5, 25 or
50 µg/kg before the induction of CIP, led to an additional and statistically significant increase in plasma
interleukin-4 concentration to a level of 410 ± 50, 450 ± 55 and 482 ± 60 pg/mL, respectively (Figure 7).
In contrast to effects observed in sensory nerves-intact rats, capsaicin deactivation of sensory
nerves abolished the CIP-evoked increase in plasma level of interleukin-4 in rats pretreated with
saline, as well as the stimulatory effect on the release of this anti-inflammatory cytokine evoked by
the combination of ghrelin plus CIP. Administration of ghrelin was also without any effect on plasma
concentration of interleukin-4 in rats with CDSN without induction of acute pancreatitis (Figure 7).
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2.2. In Vitro Studies Performed on Isolated Pancreatic Acinar Cells Obtained from Rats with Intact or
Deactivated Sensory Nerves
2.2.1. Determination of TNF-α Gene Expression and Protein Synthesis
The gene expression of pro-inflammatory cytokine, TNF-α in isolated rat pancreatic acinar cells in
the in vitro model was detected in all samples tested. In acinar cells, obtained from control sensory
nerves-intact rats treated with saline and after isolation incubated in cerulein-free solution, the ratio
of TNF-α/β-actin mRNA signal was 0.20 ± 0.02 (Figure 8). Intraperitoneal administration of ghrelin
before isolation of acinar cells from rats with intact sensory nerves did not significantly alter the ratio
of TNF-α/β-actin gene expression in comparison to control group (0.24 ± 0.02 versus 0.20 ± 0.02).
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Figure 8. Analysis of tumor necrosis factor-α (TNF-α) gene expression assessed using reverse 
transcription-polymerase chain reaction (RT-PCR) and densitometric analysis of TNF-α/β-actin 
mRNA ratio in isolated pancreatic acinar cells: (lane 1) acinar cells obtained from control sensory 
nerves (SN)-intact rats treated with saline, after isolation, acinar cells incubated in cerulein-free 
solution; (lane 2) acinar cells obtained from SN-intact rats treated with ghrelin (GHRL), after isolation, 
acinar cells incubated in cerulein-free solution; (lane 3) acinar cells obtained from SN-intact rats 
treated with saline, after isolation, acinar cells incubated in solution containing cerulein at a 
concentration of 10−8 M; (lane 4) acinar cells obtained from SN-intact rats treated with GHRL, after 
isolation, acinar cells incubated in solution containing cerulein at a concentration of 10−8 M; (lane 5) 
acinar cells obtained from rats with capsaicin deactivation of SN (CDSN) and treated with saline, after 
isolation, acinar cells incubated in solution containing cerulein at a concentration of 10−8 M; (lane 6) 
acinar cells obtained from rats with CDSN and treated with GHRL, after isolation, acinar cells 
incubated in solution containing cerulein at a concentration of 10−8 M; (lane 7) acinar cells obtained 
from rats with CDSN and treated with GHRL, after isolation, acinar cells incubated in cerulein-free 
solution. NC = negative control. Reference gene: β-actin. a p < 0.05 compared to control acinar cells 
obtained from rats with intact SN (lane 1); b p < 0.05 compared to acinar cells stimulated with cerulein 
after isolation from SN-intact rats treated with saline (line 3); c p < 0.05 compared to acinar cells 
stimulated with cerulein after isolation from SN-intact rats treated with GHRL (lane 4). In each 
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i re 8. Analysis of tumor necrosis factor-α (T F-α) e e e ressi ssesse si re erse
transcription-poly erase chain reaction (RT-PCR) and densitometric analysis of TNF-α/β-actin mRNA
ratio in isolated pancreatic acinar cells: (lane 1) acinar cells obtained from control sensory nerves
(SN)-intact rats treated with saline, after isolation, acinar cells incubated in cerulein-free solution;
(lane 2) acinar cells obtained from SN-intact rats treated with ghrelin (GHRL), after isolation, acinar
cells incubated in cerulein-free solution; (lane 3) acinar cells obtained from SN-intact rats treated
with saline, after isolation, acinar cells incubated in solution containing cerulein at a concentration of
10−8 M; (lane 4) acinar cells obtained from SN-intact rats treated with GHRL, after isolation, acinar
cells incubated in solution containing cerulein at a concentration of 10−8 M; (lane 5) acinar cells
obtained from rats with capsaicin deactivation of SN (CDSN) and treated with saline, after isolation,
acinar cells incubated in solution containing cerulein at a concentration of 10−8 M; (lane 6) acinar cells
obtained from rats with CDSN and treated with GHRL, after isolation, acinar cells incubated in solution
containing cerulein at a concentration of 10−8 M; (lane 7) acinar cells obtained from rats with CDSN
and treated with GHRL, after isolation, acinar cells incubated in cerulein-free solution. NC = negative
control. Reference gene: β-actin. a p < 0.05 compared to control acinar cells obtained from rats with
intact SN (lane 1); b p < 0.05 compared to acinar cells stimulated with cerulein after isolation from
SN-intact rats treated with saline (line 3); c p < 0.05 compared to acinar cells stimulated with cerulein
after isolation from SN-intact rats treated with GHRL (lane 4). In each experimental group, there was
at least six observations.
Hyperstimulation of ancreatic acina cells w th cerulein given at a conc tration of 10−8 M
result in a statistically significa t increase in TNF-α gene expression, the ratio of mRNA for TNF-α to
mRNA for β-actin reached a level of 1.20 ± 0.06. Peripheral administration of ghrelin, before isolation
of acinar cells from sensory intact rats, and incubation of those acinar cells with cerulein resulted in
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a statistically significant decrease in expression of mRNA for TNF-α. The ratio of TNF-α/β-actin
mRNA was 0.37 ± 0.03 (Figure 8).
CDSN performed before treatment with ghrelin, abolished the inhibitory effect of ghrelin on
TNF-α gene expression in isolated acinar cells stimulated with cerulein. Comparison of gene expression
for TNF-α in pancreatic acinar cells obtained from rats with intact sensory nerves treated with ghrelin
and rats with CDSN treated with ghrelin showed no difference between them (Figure 8).
The presence of the pro-inflammatory cytokine, TNF-α protein has been demonstrated in isolated
pancreatic acinar cells in the in vitro model in all animal groups (Figure 9). The ratio value calculated
for TNF-α/GAPDH (Glyceraldehyde-3-Phosphate Dehydrogenase) protein synthesis in isolated acinar
cells incubated in cerulein-free solution and obtained from control sensory nerves-intact rats treated
with saline was 0.098 ± 0.004. Peripheral administration of ghrelin to rats with intact sensory nerves
prior to the in vitro experiment, did not significantly affect the ratio of TNF-α/GAPDH protein,
which remained at the level of 0.11 ± 0.01 (Figure 9).
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Figure 9. Analysis of tumor necrosis factor-α (TNF-α) protein synthesis determined by the method of
immunoblotting and densitometric analysis of TNF-α/glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) protein ratio in isolated pancreatic acinar cells: (lane 1) acinar cells obtained from control
sensory nerves (SN)-intact rats treated with saline, after isolation, acinar cells incubated in cerulein-free
solution; (lane 2) acinar cells obtained from SN-intact rats treated with ghrelin (GHRL), after isolation,
acinar cells incubated in cerulein-free solution; (lane 3) acin r cells obtained from SN-intact rats treated
with saline, af er isolation, aci ar cells incubated in solution containing cerul in at a concentration of
10−8 M; (lane 4) acinar cells o tained from SN-intact rats treated with GHRL, after isolation, acinar cells
incubated in solution containing cerulein at a concentration of 10−8 M; (lane 5) acinar cells obtained
from rats with capsaicin deactivation of SN (CDSN) and treated with saline, after isolation, acinar cells
incubated in solution containing cerulein at a concentration of 10−8 M; (lane 6) acinar cells obtained from
rats with CDSN and treated with GHRL, after isolation, acinar cells incubated in solution containing
cerulein at a concentration of 10−8 M; (lane 7) acinar cells obtained from rats with CDSN and treated
with GHRL, after isolation, acinar cells incubated in cerulein-free solution. a p < 0.05 compared to
control acinar cells obtained from rats with intact SN (lane 1); b p < 0.05 compared to acinar cells
stimulated with cerulein after isolation from SN-intact rats treated ith saline (line 3); c p < 0.05
compared to acinar cells stimulated with cerulein after isolation from SN-intact rats treated with GHRL
(lane 4). In each experimental group, there was at least six observations.
The stimulation of isolated pancreatic acinar cells with cerulein, given at a supramaximal,
previously selected concentration of 10−8 M for 5 h, resulted in a statistically significant in increase
synthesis of TNF-α protein. This effect reached a similar value in acinar cells obtained from sensory
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nerves-intact rats treated with saline and rats with CDSN and treated with saline. The ratio of TNF-α
protein/GAPDH protein was in those cells 0.59 ± 0.05 and 0.63 ± 0.06, respectively (Figure 9).
Intraperitoneal administration of ghrelin, before isolation of pancreatic acinar cells, in rats with
intact sensory nerves significantly reversed the cerulein-induced increase in synthesis of TNF-α in
those cells. The ratio of TNF-α protein to GAPDH protein reached a value 0.20 ± 0.02 (Figure 9). In
contrast, the cerulein-induced increase in TNF-α synthesis was not affected by pretreatment with
ghrelin in acinar cells obtained from rats with CDSN.
CDSN failed to affect synthesis of TNF-α in acinar cells incubated in cerulein-free medium after
isolation from rats pretreated with ghrelin. The ratio TNF-α/GAPDH in those cells reached a value of
0.10 ± 0.01 and was similar to that observed in acinar cells isolated from sensory nerves-intact rats
pretreated with ghrelin and after isolation, incubated in cerulein-free medium (Figure 9).
2.2.2. Determination of Heat Shock Protein 70 (HSP70) Gene Expression and Protein Synthesis
The presence of HSP70 mRNA signal was demonstrated in vitro in isolated pancreatic acinar cells
obtained from all experimental groups. In pancreatic cells obtained from sensory nerves-intact rats
pretreated with saline (control group), the ratio of HSP70/β-actin gene expression was 0.05 ± 0.001.
Peritoneal application of ghrelin to rats 48 h prior to in vitro experiment, led to a statistically significant
increase the ratio of HSP70/β-actin gene expression to the level of 0.60 ± 0.03 (Figure 10).
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incubated in cerulein-free solution; (lane 2) acinar cells obtained from SN-intact rats treated with ghrelin
(GHRL), after isolation, acinar cells incubated in cerulein-free solution; (lane 3) acinar cells obtained
from SN-intact rats treated with saline, after isolation, cinar cells in ubated in solution containing
cerulein at a concentration of 10−8 M; (lane 4) acinar cells obtained from SN-intact rats treated with
GHRL, after isolation, acinar cells incubated in solution containing cerulein at a concentration of
10−8 M; (lane 5) acinar cells obtained from rats with capsaicin deactivation of SN (CDSN) and treated
with saline, after isolation, acinar cells incubated in solution containing cerulein at a concentration of
10−8 M; (lane 6) acinar cells obtained from rats with CDSN and treated with GHRL, after isolation,
acinar cells incubated in solution containing cerulein at a concentration of 10−8 M; (lane 7) acinar
cells obtained from rats with CDSN and tre ted with GHRL, after isolation, acinar cells incubated in
cerulein-free solution. NC = negative control. Reference gene: β-actin. a p < 0.05 compared to control
acinar cells obtained from rats with intact SN (lane 1); b p < 0.05 compared to acinar cells stimulated
with cerulein after iso ation from SN-intact rats treated with saline (line 3); c p < 0.05 compared to
acinar cells stimulated with cerulein after isolation from rats with CDSN and treated with saline
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treated with GHRL (lane 4); e p < 0.05 compared to acinar cells incubated in cerulein-free solution after
isolation from SN-intact rats treated with GHRL (lane 2). In each experimental group, there was at least
six observations.
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Stimulation of rat pancreatic acinar cells with a selected supramaximal concentration of cerulein,
10−8 M for 5 h, resulted in a statistically significant increase in the ratio HSP70/β-actin mRNA to the
level of 0.25 ± 0.01. In the in vivo model, intraperitoneal administration of ghrelin to rats, at a dose
of 50 µg/kg, 48 h before the use of the pancreatic secretagogue in vitro, resulted in a statistically
significant increase in a value ratio of HSP70/β-actin mRNA to 1.20 ± 0.06 (Figure 10).
CDSN before isolation of acinar cells from rats treated with saline produced a significant decrease
in the ratio of HSP70/β-actin mRNA in pancreatic acinar cells stimulated with cerulein in comparison
to a value observed in acinar cells obtained from sensory nerves-intact rats treated with saline
(0.01 ± 0.001 versus 1.20 ± 0.06).
Intraperitoneal administration of ghrelin to animals with CDSN in vivo prior to the administration
of cerulein at a concentration of 10−8 M in vitro, resulted in a statistically significant increase in the ratio
values of HSP70/β-actin mRNA signal in comparison to the group without administration of ghrelin.
However, this ratio was still significantly lower than that observed in acinar cells incubated with
cerulein after isolation from sensory intact-rats treated with ghrelin (0.91 ± 0.04 versus 1.20 ± 0.06).
On the other hand, the ratio HSP70/β-actin mRNA is significantly lower in acinar cells incubated
in cerulein-free solution after isolation from sensory nerves-intact rats treated with ghrelin than that
observed in acinar cells incubated in cerulein-free solution after isolation from rats with CDSN and
treated with ghrelin (0.60 ± 0.03 versus 0.85 ± 0.04) (Figure 10).
In the rat isolated pancreatic acinar cells in the in vitro model, the presence of HSP70 was detected
in all studied groups (Figure 11). The ratio of HSP70/GAPDH protein in the control group (acinar cells
obtained from sensory nerves-intact rats treated with saline, after isolation, acinar cells incubated in
cerulein-free solution) was 0.01 ± 0.001. Peripheral administration of ghrelin to sensory nerves-intact
rats prior to in vitro experiment, resulted in a statistically significant increase the ratio value to
0.15 ± 0.01.
Stimulation of pancreatic acinar cells via pancreatic secretagogue, cerulein given at a concentration
of 10−8 M for 5 h led to a statistically significant increase in cellular synthesis of HSP70 to a level of
0.06 ± 0.003 compared to HSP70 production observed in control acinar cells incubated in cerulein-free
solution. In vivo administration of ghrelin prior to cerulein usage in vitro resulted in a statistically
significant increase in the ratio of HSP70/GAPDH protein to a value of 0.28 ± 0.02 (Figure 11).
CDSN caused a dramatic, statistically significant decrease in ratio of HSP70 to GAPDH in the
pancreatic acinar cells stimulated by cerulein, at a concentration of 10−8 M, to the level of 0.003 ± 0.0001,
as compared to acinar cells incubated in cerulein containing solution and obtained from sensory
nerves-intact rats. In rats with CDSN, intraperitoneal administration of ghrelin in vivo at a dose of
50.0 µg/kg, 48 h prior to the in vitro incubation in cerulein containing solution (10−8 M), resulted
in a statistically significant increase of the ratio of HSP70 protein to GAPDH protein to the value of
0.20 ± 0.02 versus the groups without treatment with ghrelin. However, it still remained significantly
smaller compared to ratio observed in acinar cells obtained from sensory nerves-intact animals
receiving ghrelin at the same dose, followed by incubation of acinar cells in cerulein containing
solution (0.28 ± 0.02). On the other hand, the ratio of HSP70/GAPDH protein signals in pancreatic
acinar cells incubated in cerulein-free solution after isolation from animals with CDSN and treated
with ghrelin was significantly higher than that ratio observed in pancreatic acinar cells incubated in
cerulein-free solution after isolation from rats with intact sensory nerves and treated with ghrelin
(0.18 ± 0.01 versus 0.15 ± 0.01) (Figure 11).
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Figure 11. Analysis of the HSP70 protein synthesis determined by the method of immunoblotting and
densitometric analysis of TNF-α/GAPDH protein ratio in isolated pancreatic acinar cells : (lane 1) acinar
cells obtained from control sensory nerves (SN)-intact rats treated with saline, after isolation, acinar cells
incubated in cerulein-free solution; (lane 2) acinar cells obtained from SN-intact rats treated with ghrelin
(GHRL), after is lation, acinar cells incubated in cerulein-free solution; (lane 3) acinar cells obtained
from SN-inta t r ts treated with sali e, after is lation, aci ar cells in ubated i solution containing
cerulein at a concentration of 10−8 M; (lane 4) acinar cells obta ed from SN-intact rats treated with
GHRL, after isolation, acinar cells incubated in solution containing cerulei at a concentration of
10−8 M; (lane 5) acinar cells obtained from rats with capsaicin deactivation of SN (CDSN) and treated
with saline, after isolation, acinar cells incubated in solution containing cerulein at a concentration of
10−8 M; (lane 6) acinar cells obtained from rats with CDSN and treated with GHRL, after isolation,
acinar cells incubated in solution containing cerulein at a concentration of 10−8 M; (lane 7) acinar
cells obtained from rats with CDSN and treated with GHRL, after isolation, acinar cells incubated in
cerulein-free solution. a p < 0.05 compared to control acinar cells obtained from rats with intact SN
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with cerulein after isolation from SN-int ct rats treat d with GHRL (lane 4); e p < 0.05 compared to
acinar cells incubated in cerulein-free solution after isolation from SN-intact rats treated with GHRL
(lane 2). In each experimental group, there was at least six observations.
3. Discussion
Previous studies showed that pretreatment with ghrelin inhibits the development of
acute pancreatitis evoked by cerulein, taurocholate or pancreatic ischemia followed by organ
reperfusion [24–26]. Our current study confirms and extends these observations. Administration of
cerulein led to the development of acute edematous pancreatitis. Pancreases were swollen, mean
pancreatic weight was increased by more than 120%. Microscopic examination showed interlobular
and moderate or severe intralobular pancreatic edema. These alterations were accompanied by
perivascular and diffuse inflammatory infiltration, and vacuolization of acinar cells. Pretreatment
with ghrelin performed in rats with intact capsaicin-sensitive sensory nerves reduced the severity
of cerulein-induced acute pancreatitis. It reduced pancreatic edema and other histological signs
of pancreatitis. Reduction in pancreatic edema was also found as a decrease in pancreatic weight.
Moreover, pretreatment with ghrelin reduced the pancreatitis-evoked increase in plasma activity
of pancreatic digestive enzyme, lipase, and plasma concentration of pro-inflammatory cytokine,
tumor necrosis factor-α, whereas plasma concentration of anti-inflammatory cytokine, interleukin-4
was enhanced.
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The increase in plasma activity of lipase is a well-known index of acute pancreatitis development
and the severity of this disease with high sensitivity and specificity [49,50]. In our present study,
induction of acute pancreatitis led to eighty-fold increase in plasma activity of lipase in comparison
to the control value. Pretreatment with ghrelin decreased the pancreatitis-evoked increase in plasma
activity of that pancreatic digestive enzyme. This effect seems to be a result as well as a mechanism of
protective effect of ghrelin in the pancreas, which indicates that ghrelin prevents entering pancreatic
enzymes to interstitial space of the pancreas and circulation. Moreover, it was found that pancreatic
digestive enzymes, especially proteases induce leukocyte-endothelial adhesion leading to inflammatory
infiltration and microcirculatory failure in the pancreas [51]. In acute pancreatitis, leukocytes adhere
to endothelium, infiltrate pancreatic tissue and produce pro-inflammatory cytokines within this
organ [52,53]. These data are in agreement with our present observations. In rats with intact sensory
nerves, pretreatment with ghrelin reduced the cerulein-evoked increase in plasma level of lipase and
this effect was associated with reduction of leukocyte infiltration of pancreatic tissue.
However, the question remains what is the mechanism by which ghrelin prevents entering of
pancreatic enzymes to the circulation. In physiological condition, zymogen granules containing
inactive pancreatic enzymes are secreted by exocytosis at the apical part of pancreatic acinar cells to the
lumen of pancreatic acini. In the case of acute pancreatitis this process is impaired. Partly condensed
vacuoles with newly synthesized digestive enzymes accumulate at the basolateral part of the acinar cell
and form the large vacuoles containing digestive enzymes and lysosomal hydrolase, cathepsin D [54].
Later, mature zymogen granules and lysosomes also fuse with these large cathepsin D-containing
vacuoles [55–57]. Lysosomal enzymes lead to premature intracellular activation of pancreatic enzymes
and cellular organelles damage. Subsequently, these large vacuoles and individual zymogen granules
fuse with the basolateral plasma membrane, discharging their content into the interstitial space and
developing acute pancreatitis [54,57,58]. In the next step, active pancreatic digestive enzymes enter the
bloodstream. These findings are in harmony with our current studies. In agreement with previous
studies, we observed that administration of cerulein led to vacuolization of acinar cells. Vacuolization
of acinar cells should be recognized as an index of colocalization of lysosomes and zymogens in the
large vacuoles and intracellular activation of pancreatic enzymes. Our present study also showed that
pretreatment with ghrelin before cerulein administration reduces vacuolization of acinar cells. This
finding is an evidence that ghrelin decreases the cerulein-induced premature activation of pancreatic
enzymes within acinar cells.
Our current studies also showed that administration of ghrelin reduces inflammatory leukocyte
infiltration of the pancreas in cerulein-induced pancreatitis. Reduction in inflammatory infiltration
decreases pancreatic damage and for this reason also reduces premature intrapancreatic activation of
digestive enzymes and release of these enzymes into the circulation. Moreover, the development of
acute pancreatitis is associated with generation of reactive oxygen species [59]. Excess free oxygen
radicals cause oxidative damage of cellular lipids, proteins and nucleic acids. Peroxidation of cellular
lipids is the first step of reactive oxygen species-mediated cellular damage. Previous studies indicated
that treatment with ghrelin reduces lipid peroxidation and increases the activity of enzymes involved
in deactivation of free oxygen radicals [29]. These findings show a further mechanism of action of
ghrelin, which leads to a decrease in plasma level of active pancreatic enzymes.
Tumor necrosis factor-α (TNF-α) is the best-known member of a cytokine family called the tumor
necrosis factor superfamily [60]. TNF-α is a cell signaling cytokine involved in wide spectrum of
responses to stress and injury. It is mainly produced by macrophages and other immune cells, such as
monocytes, lymphocytes, natural killer cells, neutrophils and eosinophils. However, TNF-α can be
also produced by many other cell types, including pancreatic acinar cells [61]. This cytokine exhibits
host-damaging effects in different autoimmune and inflammatory diseases. TNF-α is an activator of
immune cells and regulates the synthesis of other pro-inflammatory cytokines and leukocyte adhesion
molecules. It is an endogenous pyrogen and, for this reason, it may induce fever. Moreover, this
pro-inflammatory cytokine activates the cell death signaling, leading to cell apoptosis. It may induce
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cachexia and inhibit tumorigenesis, and viral replication [60,62]. Numerous studies indicate that
TNF-α plays a pivotal role in the development of severe acute pancreatitis. Measurement of serum
TNF-α concentration was suggested to be useful biomarker in predicting severe pancreatitis and
development of multiorgan failure or septic shock [63]. However, TNF-α is rapidly cleared from the
circulation and for this reason the potential prognostic value of its measurement is limited to the first
days after the onset of the disease [62,63].
In our current study, we found that pretreatment with ghrelin in rats with intact sensory nerves
reduces the pancreatitis-induced increase in plasma concentration of TNF-α. This finding was in
line with our observation that administration of ghrelin reduces pancreatic leukocyte infiltration.
In addition, these findings taken together indicate that protective effect of ghrelin in cerulein-induced
pancreatitis in sensory nerves-intact rats involves anti-inflammatory effect of this polypeptide.
The next interesting finding of our current study is observation that induction of acute
pancreatitis by cerulein increases plasma level of interleukin-4 (IL-4) and pretreatment with ghrelin
dose-dependently enhances this effect. On the other hand, ghrelin did not affect plasma level of
IL-4 in rats without induction of acute pancreatitis. Previous studies showed that IL-4 exhibits
anti-inflammatory effects. Hart et al. reported that IL-4 suppresses the production of pro-inflammatory
interleukin-1β (IL-1β) and TNF-α by monocytes stimulated with lipopolysaccharide and interferon γ,
and this effect is similar to that obtained with dexamethasone [64]. Similar effects were obtained by
Vannier et al. [65]. They found that IL-4 inhibits the lipopolysaccharide-induced synthesis of IL-1β in
human peripheral blood mononuclear cells and enhanced the lipopolysaccharide-induced synthesis of
anti-inflammatory IL-1 receptor antagonist. Anti-inflammatory effect of IL-4 was also found in acute
pancreatitis. Protective and therapeutic effect of IL-4 in severe taurocholate-induced acute pancreatitis
was reported by Zhang et al. [66]. IL-4 reduced necrosis in this model of acute pancreatitis and authors
suggested that this effect was related to enhanced expression of complement regulatory proteins,
CD55 and CD59. In addition, clinical studies indicate that IL-4 affects the development and course
of acute pancreatitis. Acute pancreatitis, as well as endoscopic retrograde cholangiopancreatography
(ERCP) increases serum level of interleukin-4. Kilciler et al. found that 24 h after ERCP, a level of
interleukin-4 is significantly lower in patients with post-ERCP pancreatitis than in those without
pancreatitis [67]. This observation suggests that the development of acute pancreatitis is the effect of
imbalance between pro- and anti-inflammatory factors, while maintaining a balance between those
factors prevent the development of inflammation. Too low level of anti-inflammatory IL-4 or too low
increase in serum level of this cytokine in response to the presence of pro-inflammatory factors can
disturb this balance and lead to the development of acute pancreatitis and/or increase in its severity.
On the other hand, IL-4 was shown to stimulate the class of macrophages named alternatively activated
macrophages [68]. Alternatively activated macrophages are involved in dampening inflammation and
promotion of wound healing, fibrosis, and tumorigenesis. Study of Xue et al. [68] showed that mouse
and human pancreatic stellate cells are source of IL-4/IL-13 and a cross talk between macrophages and
pancreatic stellate cells is associated with the development and progression of chronic pancreatitis.
Our present study showed that ghrelin enhances the pancreatitis-evoked increase in plasma level
of IL-4. Those data could suggest that administration of ghrelin may promote the development of
chronic pancreatitis. Fortunately, our present study also showed that ghrelin does not affect plasma
level of interleukin-4 in rats without induction of acute pancreatitis. For this reason, the probability
that administration of ghrelin may stimulate the development of chronic pancreatitis is minimal.
Numerous clinical [69–72] and experimental [73–76] studies showed that disturbance in pancreatic
microcirculation can be a primary cause of acute pancreatitis. Moreover, pancreatic microcirculation
disorder and pancreatic ischemia are observed in acute pancreatitis evoked by primary non-vascular
mechanism, and always these alterations increase the severity of this disease [73,74,77]. On the other
hand, the improvement of blood flow through pancreatic vessels inhibits the development of acute
pancreatitis and accelerates the recovery in this disease [43,78,79]. Our present study showed that after
a 5-h administration of cerulein, pancreatic blood flow was reduced by around 40% in comparison
Int. J. Mol. Sci. 2017, 18, 1402 16 of 28
to value observed in sensory nerves-intact rats without induction of acute pancreatitis. Pretreatment
with ghrelin given intraperitonelly at the dose of 12.5, 25 or 50 µg/kg was without any significant
effect on pancreatic blood flow in sensory nerves-intact rats without induction of acute pancreatitis,
as well as in rats with induction of acute pancreatitis. We only found that pretreatment with ghrelin
exhibits an insignificant tendency to improve pancreatic blood flow in sensory nerves-intact rats with
acute pancreatitis. These observations are in agreement with previous studies showing lack of effect
of pretreatment with ghrelin on pancreatic blood flow in cerulein- or ischemia/reperfusion-induced
pancreatitis [24,26]. In contrast, long-term treatment with ghrelin after induction of cerulein- or
ischemia/reperfusion-induced pancreatitis improved pancreatic blood flow [27,28]. These data taken
together with our current observation suggests that influence of ghrelin on pancreatic blood flow in
the course of acute pancreatitis is indirect effect likely due to improvement of pancreatic morphology.
For this reason, short term observation was not able to demonstrate any effect in pancreatic circulation
after a single dose of ghrelin.
We may also speculate that the lack of beneficial effects of ghrelin on pancreatic blood flow
is associated with activation of coagulation in pancreatic vessels. Numerous experimental and
clinical studies showed that coagulative disorders occur in acute pancreatitis [80–84]. Acute
pancreatitis stimulates intravascular coagulation with formation of thrombi within blood vessels and
coagulation disorders may be in the range between scattered intravascular thrombosis in pancreatic
microcirculation to severe disseminated intravascular coagulation [84]. Moreover, animals and clinical
studies showed that treatment with heparin or anticoagulants inhibits the development of acute
pancreatitis and accelerates the recovery in this disease [85–93]. These findings indicate that disorders
of coagulation play the important role in acute pancreatitis and these disorders may be responsible for
the lack of significant improvement in pancreatic blood flow in animals treated with ghrelin despite
improved histology of the pancreas.
The major finding of current research was to determine the role of sensory nerves in the protective
effect of ghrelin in cerulein-induced pancreatitis. Ablation of sensory nerves by neurotoxic doses of
capsaicin performed before induction of acute pancreatitis significantly reduced plasma concentration
of anti-inflammatory IL-4 and showed a tendency to an additional increase in pancreatic weight and
decrease in pancreatic blood flow. However, the last two changes were not statistically significant.
Other parameters tested were not affected by ablation of sensory nerves and those observation are
similar to that observed previously in cerulein-induced pancreatitis [40,42,43]. These data indicate
that ablation of sensory nerves reduces endogenous anti-inflammatory mechanisms in the pancreas
and moderately increases pancreatic damage in acute pancreatitis. On the other hand, ablation of
sensory nerves totally abolished the protective effect of ghrelin in this model of acute pancreatitis.
In rats with ablation of sensory nerves before induction of acute pancreatitis, pretreatment with
ghrelin was without any effect on morphological signs of pancreatic damage, pancreatic weight,
plasma level of pancreatic digestive enzyme, lipase or plasma concentration of TNF-α and IL-4. These
observations indicate that sensory nerves mediate protective effect of ghrelin in the pancreas. This
concept is supported by study performed by Date et al. [94]. They found the presence of ghrelin
receptors in vagal afferent neurons. Vagotomy or capsaicin-induced deactivation of the gastric vagal
afferent neurons eliminated ghrelin-induced food intake, growth hormone secretion, and activation of
neuropeptide Y- and GH-RH-producing neurons [94].
Our current studies showed that ablation of sensory nerves by neurotoxic doses reduces pancreatic
blood flow in basal condition without induction of acute pancreatitis. In rats treated with ghrelin after
deactivation of sensory nerves, pancreatic blood flow was significantly reduced in comparison to a
level observed in sensory nerves-intact rats without induction o acute pancreatitis and treated with
saline or ghrelin. This observation brought two important pieces of information First, it indicates that,
under basic conditions, sensory nerves exhibit tonic activity and participate in maintaining adequate
blood flow in the pancreas. This effect seems to be related to the ability of the sensory nerves to
local release of vasoactive neuromediators, mainly calcitonin gene-related peptide (CGRP) [31–33].
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Stimulation of sensory nerves results in the release of these neuromediators, leading to vasodilatation
and increase in organ blood flow [40]. Second, ablation of sensory nerves decreases plasma and tissue
level of CGRP [35]. Results of this part of the study also showed that administration of ghrelin is not
able to reverse the negative effect of sensory nerve ablation on pancreatic blood flow. This lack of
improvement in blood flow following administration of ghrelin additionally supports the thesis about
the essential role of sensory nerves in the protective action of ghrelin in the pancreas.
The last part of our present study was conducted to determine the effect of sensory nerve ablation
and the administration of ghrelin, performed in rats before isolation of pancreatic acini, on acinar cell
expression of mRNA for TNF-α and heat shock protein 70 (HSP70) and synthesis of those proteins.
Exposure of isolated pancreatic acini to cerulein led to increase in cellular expression of mRNA for
TNF-α, as well as cellular synthesis of TNF-α. In acinar cells obtained from sensory nerves-intact rats
pretreated with ghrelin, expression mRNA for TNF-α and synthesis of this pro-inflammatory cytokine
after incubation with cerulein was reduced. On the other hand, pretreatment with ghrelin was without
any effect on expression of mRNA for TNF-α and synthesis of TNF-α under basic condition without
the presence of cerulein. Ablation of sensory nerves, before isolation of pancreatic acini, abolished the
inhibitory effect of ghrelin on the cerulein-induced expression of mRNA for TNF-α and synthesis of
this protein.
These observations provide some important information. First, these data indicate that
acinar cells may play the active role in the development of inflammation in acute pancreatitis
by releasing pro-inflammatory cytokine, TNF-α. This finding is agreement with observations of
Gukovskaya et al. [95]. They found that pancreatic acinar cells produce, release, and respond to TNF-α.
In addition, this part of our study brings additional evidence that ghrelin exhibits the anti-inflammatory
and protective effect in acute pancreatitis. Our present study also showed that protective effect of
ghrelin on the pancreas involves the action of ghrelin on the level of pancreatic acinar cells. Moreover,
these in vitro studies confirm and extend our current observations obtained in the first part of our
research in animal model of acute pancreatitis that the protective effect of ghrelin in acute pancreatitis
is mediated by capsaicin-sensitive sensory nerves.
The next interesting discovery of our current study is the observations on the effect of ghrelin
on expression and production of HSP70 in isolated pancreatic acini. HSPs are highly conserved
cytoprotective proteins. Their synthesis can be induced by various stressors such as hyper- and
hypothermia, toxins, heavy metals, and free radicals [96]. HSPs play a role of molecular chaperons in
folding newly synthesized cell proteins and assisting in the refolding of damaged proteins. HSP70
is located in all cellular compartments, including the endoplasmic reticulum, mitochondria, cytosol
and nucleus [97]. Previous studies performed on the animals demonstrated that both, thermal and
non-thermal stresses inhibit the development of cerulein-induced pancreatitis and prevent premature
trypsinogen activation in pancreatic tissue and this effect was shown to be mediated by HSP70 [98].
HSPs are also involved in thermal-induced protection against arginine- and taurocholate-induced
acute pancreatitis [99,100]. Protective effect of ischemic preconditioning in the pancreas is associated
with increase in synthesis of HSP70 [101]. The protective mechanisms of HSPs in the pancreas include
stabilization and refolding of damaged proteins, resistance of cells to apoptosis or necrosis, decrease
in the level of pro-inflammatory cytokines, antioxidant effects and inhibition of zymogen activation
within pancreatic acinar cells [96,98,102]. Our present observation that incubation of isolated pancreatic
acini with cerulein induces production of HSP70 in acinar cells is in harmony with previous studies
showing the increase in HSP70 at the mRNA and protein level in the pancreas in cerulein-induced
acute pancreatitis [103,104]. The major finding of this part of our present research is observation that
administration of ghrelin stimulates the expression of mRNA for HSP70 and production of HSP70 in
pancreatic acini isolated from rats with intact sensory nerves. This effect was found in acini incubated
in a cerulein-depleted medium. Moreover, the administration of ghrelin augmented the stimulatory
effect of cerulein on HSP expression and production. In contrast, ghrelin failed to induce expression
and production of HSP70 in pancreatic acini obtained from rats with ablated capsaicin-sensitive
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sensory nerves. These findings are the next evidence that the maintenance of sensory nerves integrity
is necessary for protective effect of ghrelin in the pancreas.
4. Material and Methods
The research was conducted in accordance with the protocols approved by the Jagiellonian
University Ethical Committee for Research and Animal Ethics. Experiments were carried out in two
series: in vivo and in vitro studies.
4.1. In Vivo Studies
4.1.1. Animals and Treatment
In vivo studies were performed on male Wistar rats weighing 170–200 g. Rats were housed in
cages in standard conditions at room temperature with a normal circadian rhythm; 12-h day/night
cycle. During a one-week period of acclimation to a new environment, food (commercial pellet chow)
and water were available ad libitum.
All experimental procedures performed in this study were approved by the Jagiellonian University
Ethical Committee on Animals Experimentation (Permit No ZI/UJ/118/2001 released on July 20, 2001).
Animals were deprived of food with free access to water 24 h prior to the start of experiment.
Rats participating in in vivo studies were randomly divided into 11 experimental groups
(each containing 10–15 animals) as follows:
(1) Control group: sensory nerves-intact rats treated with saline given as a single intaperitoneal (i.p.)
injection followed by subcutaneous (s.c.) infusion for 5 h;
(2) Sensory nerves-intact rats treated with ghrelin given at a dose of 12.5 µg/kg as single i.p. injection
followed by s.c. infusion of saline for 5 h;
(3) Sensory nerves-intact rats treated with ghrelin given at a dose of 25 µg/kg as single i.p. injection
followed by s.c. infusion of saline for 5 h;
(4) Sensory nerves-intact rats treated with ghrelin given at a dose of 50 µg/kg as single i.p. injection
followed by s.c. infusion of saline for 5 h;
(5) Sensory nerves-intact rats treated with saline given as single i.p. injection followed by induction
of acute pancreatitis (AP) by s.c. infusion of cerulein for 5 h;
(6) Sensory nerves-intact rats treated with ghrelin given at a dose of 12.5 µg/kg as single i.p. injection
followed by induction of AP by s.c. infusion of cerulein for 5 h;
(7) Sensory nerves-intact rats treated with ghrelin given at a dose of 25 µg/kg as single i.p. injection
followed by induction of AP by s.c. infusion of cerulein for 5 h;
(8) Sensory nerves-intact rats treated with ghrelin given at a dose of 50 µg/kg as single i.p. injection
followed by induction of AP by s.c. infusion of cerulein for 5 h;
(9) Rats with capsaicin deactivation of sensory nerves (CDSN) treated with saline given as single i.p.
injection followed by induction of AP by s.c. infusion of cerulein for 5 h;
(10) Rats with CDSN treated with ghrelin given at a dose of 50 µg/kg as single i.p. injection followed
by induction of AP by s.c. infusion of cerulein for 5 h; and
(11) Rats with CDSN treated with ghrelin given at a dose of 50 µg/kg as single i.p. injection followed
by s.c. infusion of saline for 5 h.
Acute pancreatitis (AP) was induced by s.c. infusion of cerulein (Takus, Pharmacia, GmbH,
Erlangen, Germany) at a dose of 5 µg/kg/h for 5 h. Cerulein was diluted in saline and infused
at a rate of 1 mL/h. Control groups received s.c. infusion of saline for 5 h (1 mL/h) as described
previously [105]. Thirty minutes before the start of cerulein or saline infusion, rats were treated
with tramadol (Poltram, Polpharma, Starogard Gdański, Poland) given intramuscularly at a dose of
1 mg/kg to minimize pain and distress. During s.c. infusion of cerulein or saline, conscious rats were
placed in individual Bollman cages. All experiments were carried out in the morning.
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Capsaicin deactivation of sensory nerves (CDSN) was performed by neurotoxic doses of capsaicin
(Fluka, Buchs, Switzerland) given s.c. during 3 days at a total dose of 100.0 mg/kg, 7 days prior to
induction of acute pancreatitis or infusion of saline [106].
Ghrelin (Bachem AG, Budendorf, Switzerland) dissolved in 0.5 mL of 0.9% NaCl, was given
i.p. to rats with intact sensory nerves or rats with CDSN, 30 min before the infusion of 0.9% NaCl
(control group) or cerulein (AP). Rats with intact sensory nerves were treated with ghrelin given
at a dose of 12.5, 25 or 50 µg/kg. Rats with CDSN were treated with ghrelin given at one dose of
50 µg/kg, because this dose exhibited the greatest protective effect on the pancreas in rats with intact
sensory nerves.
4.1.2. Determination of Pancreatic Blood Flow
Following 5-h infusion of saline or cerulein, the rats were anesthetized with pentobarbital
(30 mg/kg i.p., Vetbutal, Biowet, Puławy, Poland) and then the abdominal cavity was opened.
Pancreatic blood flow was measured by a laser Doppler flowmeter using a Laserflo, model BPM 403 A
(Blood Perfusion Monitor, Vasdamedics Inc., St. Paul, MN, USA) as previously described [107]. Blood
flow was measured in five different pancreatic regions in each rat and expressed as the percent change
of the control value.
4.1.3. Biochemical Parameters
Immediately after the measurement of pancreatic blood flow, blood samples were taken from
the inferior vena cava for plasma measurement of lipase, tumor necrosis factor-α (TNF-α) and
interleukin-4 (IL-4).
Lipase activity was determined using LIPA DT Slides (Vitros DT Chemistry System,
Johnson & Johnson Clinical Diagnostic, Inc., Rochester, NY, USA). The reading was made using the
Kodak Ectachem DT II System analyzer (Eastman Kodak Company, Rochester, NY, USA) [108].
TNF-α and IL-4 concentrations were determined by immunoenzymatic assay (ELISA) using rat
diagnostic tests (Biosource International, Camarillo, CA, USA) [107].
4.1.4. Pancreatic Weight and Histological Examination
The pancreas was carefully isolated from the abdominal cavity of each animal, purified from
adipose tissue, rinsed in 0.9% NaCl, filtered and weighed.
Histological studies were carried out on pancreatic samples fixed in 10% formalin and stained with
hematoxylin and eosin (H&E). Specimens were examined by a professional pathologist. Histological
grading of pancreatic edema, leukocyte inflammatory infiltration, vacuolization of acinar cells was
made using a scale ranging from 0 to 3 as described previously in detail [108,109]:
1. pancreatic edema (0—no edema, 1—interlobar edema, 2—interlobar and moderate intralobular
edema, 3—severe interlobula and intralobular edema);
2. leukocyte inflammatory infiltration (0—Absent, 1—scarce perivascular infiltration, 2—moderate
perivascular and scarce diffuse infiltration, 3—abundant diffuse infiltration);
3. vacuolozation of acinar cells (0—absent, 1—involving less than 25% of acinar cells, 2—involving
from 25 to 50% acinar cells, 3—involving more than 50% of acinar cells);
4. necrosis of acinar cells (0—absent, 1—involving less than 15% of acinar cells, 2—involving from
15 to 35% acinar cells, 3—involving more than 35% of acinar cells); and
5. hemorrhage (0—absent, 1 from 1 to 2 foci per slide, 2—from 3 to 5 foci per slide, 3—more than
5 foci per slide).
The results of histological examination were shown as predominant histological grading (mode)
of pancreatic edema, inflammatory infiltration and vacuolization of acinar cells in each experimental
group (Table 1). Moreover, we showed the representative morphological features of the pancreas in
main experimental groups in Figure 2 and the total histological score of pancreatic damage calculated
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as the sum of degrees of pancreatic edema, inflammatory infiltration and vacuolization of acinar cells
as described previously [110].
4.2. In Vitro Studies
Isolated acinar cells were obtained from rats with intact sensory nerves or rats with CDSN.
Rats were treated with ghrelin given i.p. at single dose of 50 µg/kg or with saline and 48 h later
as described previously [111], animals were again anesthetized with pentobarbital. The abdominal
cavity was opened and the pancreas was carefully dissected out from its attachment to the stomach,
duodenum and spleen. Pancreatic acinar cells were isolated by collagenase digestion as described
previously [112,113] and incubated in cerulein-free or cerulein containing solution. Previous studies
showed that cerulein given at a concentration of 10−8 M and 5-h incubation were most effective in
stimulating exocrine secretion and gene expression in pancreatic acinar cells [114,115], thus these
concentration of cerulein and time of incubation were selected for our current in vitro studies. Studies
in each experimental group were repeated at least six times.
During the in vitro studies, we used following experimental groups:
(1) acinar cells obtained from control sensory nerves-intact rats treated i.p. with saline; after isolation,
acinar cells incubated in cerulein-free solution;
(2) acinar cells obtained from sensory nerves-intact rats treated i.p. with ghrelin at a dose of 50 µg/kg;
after isolation, acinar cells incubated in cerulein-free solution;
(3) acinar cells obtained from sensory nerves-intact rats treated i.p. with saline; after isolation, acinar
cells incubated in solution containing cerulein at a concentration of 10−8 M;
(4) acinar cells obtained from sensory nerves-intact rats treated i.p. with ghrelin at a dose of 50 µg/kg;
after isolation, acinar cells incubated in solution containing cerulein at a concentration of 10−8 M;
(5) acinar cells obtained from rats with CDSN treated i.p. with saline; after isolation, acinar cells
incubated in solution containing cerulein at a concentration of 10−8 M;
(6) acinar cells obtained from rats with CDSN treated i.p. with ghrelin at a dose of 50 µg/kg;
after isolation, acinar cells incubated in solution containing cerulein at a concentration of
10−8 M; and
(7) acinar cells obtained from rats with CDSN treated i.p. with ghrelin at a dose of 50 µg/kg;
after isolation, acinar cells incubated in cerulein-free solution.
4.2.1. Determination of TNF-α and Heat Shock Protein 70 (HSP70) Gene Expression by Reverse
Transcription-Polymerase Chain Reaction (RT-PCR)
The isolation of total cellular RNA was performed employing TRIzol Reagent (Gibco-BRL,
Life Technologies, Gaithersburg, MD, USA) in accordance with the manufacturer’s protocol [116].
Precipitated in the final step of isolation, RNA was resuspended in RNase-free water. Final
concentration of the RNA isolates was estimated by the measurement of absorbance at
260 nm wavelength. To establish the purity of the isolates calculation of A260/A280 ratio
was done. The integrity of RNA isolates was confirmed by electrophoresis in formaldehyde
denaturizing conditions.
cDNA synthesis was performed employing the Reverse Transcription System (Promega Corp.,
Madison, WI, USA) using 1 µg of RNA according to the manufacturers protocol. Two of the cDNAs
were used for polymerase chain reaction. Promega PCR reagents were used in all PCR reactions.
Specific primers were synthesized by Sigma-Genosys (Pampisford, UK). Semi-quantitative analysis of
the abundance of cDNA product for each sample was performed using Foto/Analyst Fotodyne System
(Fotodyne Inc., Hartland, WI, USA) on ethidium bromide stained 2% agarose gel. O’Gene Ruler 50 bp
DNA Ladder (Fermentas GmbH, St. Leon-Rot, Germany) was used to confirm the predicted location
of the PCR products. Results of the semi-quantitative analysis were expressed as a ratio using β-actin
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gene product as a reference for each sample. PCR negative and positive reaction controls were added
in all experiments to confirm specificity of reaction.
The gene, primer sequences, product length, characteristic annealing temperatures and references
are summarized in Table 2.
Table 2. Gene, primers’ sequences, product length, annealing temperatures, references.
Gene Sequence 5′→ 3′ Product (bp) AnnealingTemperature (◦C) Reference
β-actin Sense: TTG TAA CCA ACT GGG ACG ATA TGG 764 60 [117]Antisense: GAT CTT GAT CTT CAT GGT GCT AGG
TNF-α
Sense: TAC TGA ACT TCG GGG TGA TTG GTC C
295 60 [118]Antisense: CAG CCT TGT CCC TTG AAG AGA ACC
HSP70
Sense: GTG AAG ATC TGC GTC TGC TTG
590 60 [104]Antisense: TTT GAC AAC AGG CTG GTG AAC C
4.2.2. Determination of TNF-α and HSP70 Protein Synthesis by Immunoblotting
The whole cell protein extracts from rat pancreatic acinar cells were prepared as described
previously [119]. Samples containing 5–10 µg of proteins were separated under denaturing condition
in 12% polyacrylamide gel. Following separation samples were transferred onto the PVDF membrane
(BioRad, Hecules, CA, USA) and membranes were blocked for 2 h at room temperature in blocking
buffer (5% non-fat dried milk in PBS). Membranes containing immobilized protein samples were
exposed to the primary antibody diluted 1:1000 for 1 h at room temperature on the agitating
platform. After antibody probing membranes were washed three times for 10 min in TBST buffer
(0.1 M Tris pH 8.0; 1.5 M NaCl; 0.5% TritonX-100). Suitable secondary antibody in the dilution 1:5000
in blocking buffer was applied for 1 h at room temperature. Following the secondary antibodies
probing, washing procedure was performed as described above. Each blot was stripped and probed
with GAPDH antibody to confirm equal protein loading. Proteins complexed with antibodies were
detected using Super Signal West Pico Chemiluminescent Substrate Thermo Fisher Scientific (Waltham,
MA, USA) according to the manufactures protocol. All presented results were obtained in six
consecutive experiments.
All primary antibodies: mouse monoclonal IgG1 anti GAPDH (A-3); goat polyclonal IgG anti
TNF–α (R–19); mouse monoclonal IgG1 anti HSP70 (3A3) as well as secondary goat anti-mouse
IgG1-HRP conjugated and rabbit anti-goat IgG-HRP conjugated were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, USA).
4.3. Statistical Analysis
Results are expressed as means ± SEM. A statistical analysis was done by one-way analysis
of variance (ANOVA), followed by Tukey’s multiple comparison test. A statistical analysis was
conducted using the statistical package GraphPad Prism (GraphPad Software, San Diego, CA, USA).
Differences with p < 0.05 were considered significant.
5. Conclusions
Our present study has demonstrated that ghrelin exhibits the protective effect in cerulein-induced
acute pancreatitis on the organ and pancreatic acinar cell level. The maintenance of sensory nerve
integrity is necessary for this effect.
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Tomaszewska, R.; Ambroży, T.; Dembiński, A. Protective Effect of Pretreatment with Acenocoumarol in
Cerulein-Induced Acute Pancreatitis. Int. J. Mol. Sci. 2016, 17, E1709. [CrossRef] [PubMed]
91. Rabenstein, T.; Roggenbuck, S.; Framke, B.; Martus, P.; Fischer, B.; Nusko, G.; Muehldorfer, S.; Hochberger, J.;
Ell, C.; Hahn, E.G.; et al. Complications of endoscopic sphincterotomy: Can heparin prevent acute
pancreatitis after ERCP? Gastrointest. Endosc. 2002, 55, 476–483. [CrossRef] [PubMed]
92. Ung, K.A.; Rydberg, L.; Modin, S.; Kylebäck, A.; Modin, M. A preventive effect of unfractionated heparin on
post-ERCP pancreatitis is suggested by positive effects on laboratory markers. Hepatogastroenterology 2011,
58, 168–173. [PubMed]
93. Alagözlü, H.; Cindoruk, M.; Karakan, T.; Unal, S. Heparin and insulin in the treatment of
hypertriglyceridemia-induced severe acute pancreatitis. Dig. Dis. Sci. 2006, 51, 931–933. [CrossRef]
[PubMed]
94. Date, Y.; Murakami, N.; Toshinai, K.; Matsukura, S.; Niijima, A.; Matsuo, H.; Kangawa, K.; Nakazato, M.
Nerve ablation showed a tendency to induce an additional increase in pancreas mass and pancreatic blood
flow. Gastroenterology 2002, 123, 1120–1128. [CrossRef] [PubMed]
95. Gukovskaya, A.S.; Gukovsky, I.; Zaninovic, V.; Song, M.; Sandoval, D.; Gukovsky, S.; Pandol, S.J. Pancreatic
acinar cells produce, release, and respond to tumor necrosis factor-α. Role in regulating cell death and
pancreatitis. J. Clin. Investig. 1997, 100, 1853–1862. [CrossRef] [PubMed]
96. Rakonczay, Z.; Takács, T.; Boros, I.; Lonovics, J. Heat shock proteins and the pancreas. J. Cell. Physiol. 2003,
195, 383–391. [CrossRef] [PubMed]
Int. J. Mol. Sci. 2017, 18, 1402 27 of 28
97. Robert, J.; Ménoret, A.; Basu, S.; Cohen, N.; Srivastava, P.R. Phylogenetic conservation of the molecular and
immunological properties of the chaperones GP96 and HSP70. Eur. J. Immunol. 2001, 31, 186–195. [CrossRef]
98. Frossard, J.L.; Bhagat, L.; Lee, H.S.; Hietaranta, A.J.; Singh, V.P.; Song, A.M.; Steer, M.L.; Saluja, A.K. Both
thermal and non-thermal stress protect against caerulein induced pancreatitis and prevent trypsinogen
activation in the pancreas. Gut 2002, 50, 78–83. [CrossRef] [PubMed]
99. Tashiro, M.; Ernst, S.A.; Edwards, J.; Williams, J.A. Hyperthermia induces multiple pancreatic heat shock
proteins and protects against subsequent arginine-induced acute pancreatitis in rats. Digestion 2002, 65,
118–126. [CrossRef] [PubMed]
100. Rakonczay, Z.; Takács, T.; Iványi, B.; Mándi, Y.; Pápai, G.; Boros, I.; Varga, I.S.; Jost, K.; Lonovics, J. The effects
of hypo- and hyperthermic pretreatment on sodium taurocholate-induced acute pancreatitis in rats. Pancreas
2002, 24, 83–89. [CrossRef] [PubMed]
101. Warzecha, Z.; Dembinski, A.; Ceranowicz, P.; Konturek, S.J.; Dembinski, M.; Pawlik, W.W.; Tomaszewska, R.;
Stachura, J.; Kusnierz-Cabala, B.; Naskalski, J.W.; et al. Ischemic preconditioning inhibits development
of edematous cerulein-induced pancreatitis: Involvement of cyclooxygenases and heat shock protein 70.
World J. Gastroenterol. 2005, 11, 5958–5965. [CrossRef] [PubMed]
102. Takayama, S.; Reed, J.C.; Homma, S. Heat-shock proteins as regulators of apoptosis. Oncogene 2003, 22,
9041–9047. [CrossRef] [PubMed]
103. Weber, C.K.; Gress, T.; Müller-Pillasch, F.; Lerch, M.M.; Weidenbach, H.; Adler, G. Supramaximal
secretagogue stimulation enhances heat shock protein expression in the rat pancreas. Pancreas 1995, 10,
360–367. [CrossRef] [PubMed]
104. Konturek, P.C.; Dembinski, A.; Warzecha, Z.; Burnat, G.; Ceranowicz, P.; Hahn, E.G.; Dembinski, M.;
Tomaszewska, R.; Konturek, S.J. Pioglitazone, a specific ligand of peroxisome proliferator-activated
receptor-γ, protects pancreas against acute cerulein-induced pancreatitis. World J. Gastroenterol. 2005,
11, 6322–6329. [CrossRef] [PubMed]
105. Jaworek, J.; Bonior, J.; Tomaszewska, R.; Jachimczak, B.; Kot, M.; Bielański, W.; Pawlik, W.W.; Sendur, R.;
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